3756 Federal Register / Vol. 63, No. 16 / Monday, January 26, 1998 / Notices

808(2), this notice with comment period

is effective January 1, 1998, for

allotments for payments of Medicare

Part B premiums for individuals in

calendar year 1998 from the allotment

for fiscal year 1998.

V. Regulatory Impact Statement

We have examined the impact of this

notice with comment period as required

by Executive Order 12866 and the

Regulatory Flexibility Act (RFA) (Pub.

L. 96–354). Executive Order 12866

directs agencies to assess all costs and

benefits of available regulatory

alternatives and, when regulation is

necessary, to select regulatory

approaches that maximize net benefits

(including potential economic,

environmental, public health and safety

effects; distributive impacts; and

equity). The RFA requires agencies to

analyze options for regulatory relief for

small businesses. For purposes of the

RFA, States and individuals are not

considered to be small entities.

This notice with comment period

implements provisions of the Balanced

Budget Act of 1997 to allocate, among

the States, Federal funds to provide

Medicaid payment for Medicare Part B

premiums for two additional groups of

low-income Medicare beneficiaries. The

total amount of Federal funds available

during a Federal fiscal year and the

formula for determining individual

State allotments are specified in the law.

We have applied the statutory formula

for the State allotments except for the

use of specified data. Because the data

specified in the law were not currently

available, we have used comparable

data from the U.S. Census Bureau on the

number of possible qualifying

individuals in the States.

We believe that the statutory

provisions implemented in this notice

with comment period will have a

positive effect on States and

individuals. Federal funding at the 100

percent matching rate is available for

Medicare cost-sharing for Medicare Part

B premium payments for qualifying

individuals and a greater number of

low-income Medicare beneficiaries will

be eligible to have their Medicare Part

B premiums paid under Medicaid.

Section 1102(b) of the Social Security

Act requires us to prepare a regulatory

impact analysis for any notice that may

have a significant impact on the

operations of a substantial number of

small rural hospitals. Such an analysis

must conform to the provisions of

section 603 of the RFA. For purposes of

section 1102(b) of the Act, we define a

small rural hospital as a hospital that is

located outside a Metropolitan

Statistical Area and has fewer than 50

beds.

We are not preparing analyses for

either the RFA or section 1102(b) of the

Act because we have determined and

certify that this notice with comment

period will not have a significant

economic impact on a substantial

number of small entities or a significant

impact on the operations of a substantial

number of small rural hospitals.

In accordance with the provisions of

Executive Order 12866, this notice with

comment period was reviewed by the

Office of Management and Budget.

Authority: Sections 1902(a)(10), 1933 of

the Social Security Act (42 U.S.C. 1396a),

and Public Law 105–33.

(Catalog of Federal Domestic Assistance

Program No. 93.778, Medical Assistance

Program)

Dated: December 12, 1997.

Nancy-Ann Min DeParle,

Administrator, Health Care Financing

Administration.

Dated: January 13, 1998.

Donna E. Shalala,

Secretary.

[FR Doc. 98–1675 Filed 1–23–98; 8:45 am]

BILLING CODE 4120–01–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

National Institute on Drug Abuse

(NIDA) Initial Review Group and

Special Emphasis Panel meetings.

Purpose/Agenda: To review and evaluate

grant applications.

Name of Committee: Neurophysiology and

Neuroanatomy Research Subcommittee.

Date: February 9–11, 1998.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Gamil Debbas, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: Human Development

Research Subcommittee.

Date: February 10, 1998.

Time: 9:00 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Kesinee Nimit, M.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

Name of Committee: Basic Behavioral

Science Research Subcommittee.

Date: February 10–12, 1998.

Time: 8:30 a.m.

Place: Key Bridge Marriott Hotel, 1401 Lee

Highway, Arlington, VA 22209.

Contact Person: Mark Swieter, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–42, Telephone (301) 443–2620.

Name of Committee: Epidemiology and

Prevention Research Subcommittee.

Date: February 10–12, 1998.

Time: 8:30 a.m.

Place: Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20814.

Contact Person: Raquel Crider, Ph.D.,

Scientific Review Administrator, Office Of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

Name of Committee: Molecular, Cellular

and Chemical Neurobiology Research

Subcommittee.

Date: February 10–12, 1998.

Time: 8:30 a.m.

Place: Ritz-Carlton Hotel at Pentagon City,

250 South Hayes Street, Arlington, VA

22202.

Contact Person: Rita Liu, Ph.D., Scientific

Review Administrator, Office of Extramural

Program Review, National Institute on Drug

Abuse, 5600 Fishers Lane, Room 10–22,

Telephone (301) 443–9042.

Name of Committee: NIDA Special

Emphasis Panel (Molecular, Cellular and

Chemical Neurobiology).

Date: February 12, 1998.

Time: 9:00 a.m.

Place: Ritz-Carlton Hotel at Pentagon City,

250 South Hayes Street, Arlington, VA

22202.

Contact Person: Mary C. Custer, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: Neuropharmacology

Research Subcommittee.

Date: February 17–19, 1998.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Syed Husain, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: Treatment Research

Subcommittee.

Date: March 2–4, 1998.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Kesinee Nimit, M.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

Name of Committee: NIDA Special

Emphasis Panel (Training and Career

Development).

Date: March 2–4, 1998.

Time: 8:30 a.m.
Federal Register / Vol. 63, No. 16 / Monday, January 26, 1998 / Notices 3757

Place: Residence Inn by Marriott, 7335

Wisconsin Avenue, Bethesda, MD 20814.

Contact Person: Mark Swieter, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–42, Telephone (301) 443–2620.

Name of Committee: Health Service

Research Subcommittee.

Date: March 3–4, 1998.

Time: 8:30 a.m.

Place: Key Bridge Marriott Hotel, 1401 Lee

Highway, Arlington, VA 22209.

Contact Person: Raquel Crider, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–9042.

Name of Committee: AIDS Biomedical and

Clinical Research Subcommittee.

Date: March 10–11, 1998.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Gamil Debbas, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: NIDA Special

Emphasis Panel (Centers).

Date: March 17, 1998.

Time: 8:30 a.m.

Place: Double Tree Hotel, 1750 Rockville

Pike, Rockville, MD 20852.

Contact Person: Mary C. Custer, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–22, Telephone (301) 443–2620.

Name of Committee: AIDS Behavioral

Research Subcommittee.

Date: March 17–18, 1998.

Time: 8:30 a.m.

Place: Sheraton-National Hotel, 900 South

Orme Street, Arlington, VA 22204.

Contact Person: Khursheed Asghar, Ph.D.,

Scientific Review Administrator, Office of

Extramural Program Review, National

Institute on Drug Abuse, 5600 Fishers Lane,

Room 10–42, Telephone (301) 443–2620.

The meetings will be closed in accordance

with provisions set forth in secs. 552b(c)(4)

and 552b(c)(6), Title 5, U.S.C. The

applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, disclosure of

which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.277, Drug Abuse

Research Scientist Development and

Research Scientist Awards; 93.278, Drug

Abuse National Research Service Awards for

Research Training; 93.279, Drug Abuse

Research Programs.)

Dated: January 16, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–1711 Filed 1–23–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the National Institute

of Mental Health Special Emphasis

Panel:

Agenda/Purpose: To review and evaluate

grant applications.

Committee Name: National Institute of

Mental Health Special Emphasis Panel.

Date: February 12, 1998.

Time: 8:30 a.m.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: W. Gregory Zimmerman,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: (301) 443–

1340.

Committee Name: National Institute of

Mental Health Special Emphasis Panel.

Date: February 13, 1998.

Time: 8:30 a.m.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: W. Gregory Zimmerman,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: (301) 443–

1340.

The meetings will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers 93.242, 93.281, 93.282)

Dated: January 16, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–1712 Filed 1–22–98; 11:41 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Mental Health;

Notice of Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meetings of the National Institute of

Mental Health Initial Review Group:

Agenda/Purpose: To review and evaluate

grant applications.

Committee Name: Services Research

Review Committee.

Date: February 10–February 11, 1998.

Time: 8:30 a.m.

Place: Hyatt Regency Bethesda, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Gavin T. Wilkom,

Parklawn, Room 9C–18, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301–443–

1340.

Committee Name: Clinical Neuroscience

and Biological Psychopathology Review

Committee.

Date: February 11–February 13, 1998.

Time: 9 a.m.

Place: One Washington Circle, One

Washington Circle, NW., Washington, DC

20037.

Contact Person: Maureen L. Eister,

Parklawn, Room 9–101, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301–443–

3936.

Committee Name: Neuropharmacology and

Neurochemistry Review Committee.

Date: February 12–February 13, 1998.

Time: 8:30 a.m.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Donna Ricketts, Parklawn,

Room 9–101, 5600 Fishers Lane, Rockville,

MD 20857, Telephone: 301–443–3936.

Committee Name: Violence and Traumatic

Stress Review Committee.

Date: February 12–February 13, 1998.

Time: 8:30 a.m.

Place: Chevy Chase Holiday Inn, 5520

Wisconsin Avenue, Chevy Chase, MD 20815.

Contact Person: Sheri L. Schwartzback,

Parklawn, Room 9C–26, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301–443–

6470.

Committee Name: Social and Group

Processes Review Committee.

Date: February 12–February 13, 1998.

Time: 8:30 a.m.

Place: The Governor’s House Hotel, 1615

Rhode Island Avenue, NW., Washington, DC

20036.

Contact Person: Tarsha Johnson, Parklawn,

Room 9–101, 5600 Fishers Lane, Rockville,

MD 20857, Telephone: 301–443–6470.

Committee Name: Health Behavior and

Prevention Review Committee.

Date: February 18, 1998.

Time: 8:30 a.m.

Place: One Washington Circle, One

Washington Circle, NW., Washington, DC

20037.

Contact Person: Monica F. Woodfork,

Parklawn, Room 9C–26, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301–443–

6470.

Committee Name: Psychobiology,

Behavior, and Neuroscience Review

Committee.

Date: February 19–February 20, 1998.

Time: 8:30 a.m.

Place: Bethesda Hyatt Regency, One

Bethesda Metro Center, Bethesda, MD 20814.

Contact Person: Deborah A. DeMasse,

Parklawn, Room 9–101, 5600 Fishers Lane,

Rockville, MD 20857, Telephone: 301–443–

3936.